Cellyan Biotechnology Co., Ltd (HKPD)
Nasdaq: HKPD · Wholesale-Drugs, Proprietaries & Druggists' Sundries · filing with the SEC since 2024
Who runs Cellyan Biotechnology Co., Ltd
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Liang Chenyu Andy
CEO and Director. First filing Jun 2026, latest Jun 8, 2026, 0 filings in all.
Officers reporting now
3
of 7 people with a filing in the last fifteen months
Directors reporting now
4
7 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Wang Zifeng | Chief Strategy Officer | Jun 2026 | Jun 9, 2026 | none |
| Liang Chenyu Andy | CEO and Director | Jun 2026 | Jun 8, 2026 | none |
| Liu Shu | CFO | Jun 2026 | Jun 8, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Chan Kam Leung | director | Jun 2026 | Jun 12, 2026 | none |
| Wong Lap Sun | director | Jun 2026 | Jun 10, 2026 | none |
| Wu Jingyan | director | Jun 2026 | Jun 8, 2026 | none |
| Zhou Mike Yao | director | Jun 2026 | Jun 8, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.